Search Results - "Evans, Elin"

180 Long Term Outcomes following Unilateral Treatment for Squamous Cell Carcinoma of Unknown Primary by Walters, Sarah Emma, Webster, Richard, Randall, Jessica, Rackley, Thomas, Evans, Elin Sian, Evans, Mererid, Palaniappan, Nachi

“…Squamous cell carcinoma of unknown primary (SCCUP) accounts for up to 5%1-4 of cancers in the head and neck region and are defined as “metastatic disease in…”
Get full text

158 PET CT response outcomes in curatively treated oropharyngeal SCC with bulky N3 neck disease by Williams, Fiona, Morley, Nicholas, Richard, Webster, Thomas, Rackley, Elin, Evans, Evans, Mererid, Palaniappan, Nachi

“…PET CT scans are used to assess the response following curative intent chemoradiotherapy (CRT) or radiotherapy (RT) for oropharyngeal SCC (OPSCC) 12 weeks…”
Get full text

179 Contralateral Neck Recurrence Following Unilateral Treatment for Oral Tongue Squamous Cell Carcinoma by John, Rebecca, Webster, Richard, Evans, Mererid, Rackley, Thomas, Evans, Elin, Palaniappan, Nachi

“…Carcinoma of the oral cavity is rare, however oral tongue carcinoma has been associated with worse prognosis when compared to other oral cavity subsites. A…”
Get full text

Principles of cancer treatment by radiotherapy by Evans, Elin, Staffurth, John

“…Radiotherapy plays an integral role in the management of more than 50% of cancer cases and 40% of patients cured of their cancer have radiotherapy as a part of…”
Get full text

FIELDRT: an open-source platform for the assessment of target volume delineation in radiation therapy by Piazzese, Concetta, Evans, Elin, Thomas, Betsan, Staffurth, John, Gwynne, Sarah, Spezi, Emiliano

“…Objectives: Target volume delineation (TVD) has been identified as a weakness in the accuracy of radiotherapy, both within and outside of clinical trials due…”
Get full text

High-grade neuroendocrine head and neck cancer: Case series and review of the literature by Fuentes, Javier David Benitez, Fouda, Sally, Evans, Elin, Palaniappan, Nachi, Rackley, Thomas, Chan, Po, Evans, Mererid, Webster, Richard

“…High-grade neuroendocrine cancers (NEC) of the head and neck (HN) are rare and aggressive, accounting for ≤1 % of all HN cancers, with a 5-year overall…”
Get full text

Pretrial outlining quality assurance in PIVITOLBoost by Evans, Elin, Mayles, Helen, Naismith, Olivia Frances, Hall, Emma, Tree, Alison, Staffurth, John, Syndikus, Isabel

“…Abstract only 50 Background: PIVOTALBoost is a Phase III randomised controlled trial (CRUK/16/018) of radiotherapy to prostate and pelvic nodes versus prostate…”
Get full text

PET-CT scan timing after radical treatment for oropharyngeal squamous-cell carcinoma at Velindre: Adherence to NICE guidelines by Williams, Fiona, Morley, Nicholas, Wyatt-Haines, Emma, Heyman, James, Rackley, Thomas, Evans, Mererid, Evans, Elin, Webster, Richard, Palaniappan, Nachi

Get full text

Novel dosimetric validation of a commercial CT scanner based deep learning automated contour solution for prostate radiotherapy by Berenato, Salvatore, Williams, Matthew, Woodley, Owain, Möhler, Christian, Evans, Elin, Millin, Anthony E., Wheeler, Philip A.

“…•OAR delineation is a critical component in modern radiotherapy pathways.•A novel dosimetric methodology was used to evaluate AI contours for prostate OARs.•3…”
Get full text

FIELD RT : an open-source platform for the assessment of target volume delineation in radiation therapy by Piazzese, Concetta, Evans, Elin, Thomas, Betsan, Staffurth, John, Gwynne, Sarah, Spezi, Emiliano

“…Target volume delineation (TVD) has been identified as a weakness in the accuracy of radiotherapy, both within and outside of clinical trials due to the…”
Get full text

On-trial radiotherapy quality assurance in NeoSCOPE: A randomised phase II trial of chemoradiotherapy in oesophageal cancer by Evans, Elin, Jones, Gareth, Radhakrishna, Ganesh, Hawkins, Maria A, Mukherjee, Somnath, Maggs, Rhydian, Ray, Ruby, Crosby, Tom David Lewis, Gwynne, Sarah

“…Abstract only 119 Background: Failure to adhere to trial protocols for target volume delineation (TVD) within radiotherapy (RT) trials may have an adverse…”
Get full text